3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
3
Melanoma
2
Endometrial Neoplasms
2
Breast Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Multiple Myeloma
1
Moderate Hepatic Impairment
1
Meningioma
1
Lymphoma
1
Lung Neoplasms
1
Locally Advanced (Inoperable) or Metastatic Breast Cancer
1
Hematologic Neoplasms
1
Glioma
1
Fallopian Tube Neoplasms
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Chondrosarcoma
1
Carcinosarcoma
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Interventions
venetoclax
5
Rituximab
5
Cyclophosphamide
5
zanubrutinib
3
Whole-Body Irradiation
3
Prednisone
3
Magnetic Resonance Spectroscopy
3
Lenalidomide
3
Cyclosporine
3
pirtobrutinib
2
fludarabine phosphate
2
fludarabine
2
Vincristine
2
Specimen Handling
2
Mycophenolic Acid
2
Doxorubicin
2
Biopsy
2
treosulfan
1
pomalidomide
1
polatuzumab vedotin
1
obinutuzumab
1
ibrutinib
1
Tacrolimus
1
Stem Cell Transplantation
1
Sirolimus
1
R-CHOP protocol
1
Peripheral Blood Stem Cell Transplantation
1
Oxaliplatin
1
Methotrexate
1
Melphalan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell, Marginal Zone
×
capivasertib
×
30 days
×
Clear all
No trials found.